The 2027 Masterclasses in Dermatology delivers a program grounded in practical, high-impact education built for today’s clinicians. Designed by leading experts, the program focuses on real-world challenges, emerging therapies, and strategies you can apply immediately in practice.

What to Expect

Case-based, real-world learning
Work through clinical decision points, everyday challenges, and complex presentations.
Advanced inflammatory disease management
Receive in-depth updates on AD, psoriasis, HS, urticaria, vitiligo, and evolving biologics.
Technology and diagnostics in practice
Explore AI, imaging, and tools such as ultrasound—where they add value in real care.
Multidisciplinary perspectives
Integrate insights across dermatology, rheumatology, gastroenterology, and more.
Real-world practice considerations
Learn about reimbursement, access, and making treatment decisions in context.
Interactive, expert-led sessions
Experience panels, Q&A, and focused masterclasses on emerging therapies and standards of care.

Designed for clinicians at every stage of practice, the program sharpens clinical judgment, strengthens decision-making, and delivers insights you can apply right away.

February 18-21, 2027 | Orlando

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
- Co-Chair
  - Alice Gottlieb MD, PhD
  - Joseph Merola MD, MMSc, FAAD, FACR
- Presenter
  - Heather Goff PhD
Medical dermatology often leaves patients with visible sequelae that continue to affect quality of life after active disease is controlled. Dyspigmentation, scarring, textural change, volume loss, and post-inflammatory changes all require careful assessment and realistic counseling. This session explores cosmetic and procedural strategies that can help restore skin health while accounting for the underlying dermatologic condition, risk of flare, pigmentary change, and patient goals.
- Presenter
  - Scott Elman MD
Inflammatory wounds are frequently mistaken for infection, vascular disease, trauma, or nonhealing surgical wounds, which can delay appropriate treatment and worsen outcomes. Using pyoderma gangrenosum as a central example, this session examines diagnostic clues, biopsy considerations, systemic associations, pathergy risk, and treatment escalation. Special attention will be given to common missteps, including unnecessary debridement and delayed immunosuppression.
- Presenter
  - Jennifer Cao MD
Ocular inflammation may be an early sign of systemic immune-mediated disease or a serious complication in patients already being treated for dermatologic conditions. This session reviews key ocular manifestations relevant to dermatology, including uveitis, episcleritis, scleritis, keratitis, conjunctivitis, and periocular inflammation. The discussion will focus on red flags, referral urgency, and how ocular findings may influence systemic treatment planning.
- Presenter
  - Manisha Thakuria
Advanced cutaneous squamous cell carcinoma requires timely recognition, risk stratification, and coordinated care across dermatology, surgery, oncology, and radiation oncology. This session reviews treatment strategy for high-risk, locally advanced, recurrent, and metastatic disease, including the evolving role of immunotherapy. Practical considerations include staging, referral timing, treatment sequencing, response assessment, and management of complex or immunosuppressed patients.
- Panelist
  - Heather Goff PhD
  - Scott Elman MD
  - Jennifer Cao MD
  - Manisha Thakuria
- Presenter
  - Brittany Weber MD, PhD
Skin findings can sometimes signal deeper systemic inflammation, including cardiovascular involvement. This session introduces cardiac imaging concepts relevant to dermatologists caring for patients with autoimmune, inflammatory, or infiltrative disease. Topics include when echocardiography, cardiac MRI, CT, PET imaging, or other modalities may be useful, along with clinical clues that should prompt collaboration with cardiology.
- Presenter
  - Katherine Economy MD
Menopause affects the skin, hair, mucosa, and vulvar health in ways that are often under-recognized in dermatology practice. This session reviews hormonal influences on xerosis, barrier dysfunction, pruritus, hair changes, vulvar dermatoses, genitourinary symptoms, and skin sensitivity. Emphasis will be placed on practical evaluation, treatment options, patient counseling, and coordination with gynecology when symptoms extend beyond routine dermatologic care.
- Presenter
  - Heather Goff PhD
The widespread use of GLP-1 receptor agonists and related anti-obesity therapies has introduced new dermatologic and aesthetic considerations. Rapid weight loss, metabolic shifts, nutritional changes, and altered body composition may contribute to facial volume loss, laxity, hair shedding, xerosis, intertrigo, and wound-healing concerns. This session offers a practical approach to recognizing these changes, distinguishing them from unrelated skin disease, and guiding patients seeking medical or cosmetic management.
- Presenter
  - Elizabeth (Lisa) Swanson MD
Nonsteroidal topical therapies are expanding options for children with chronic inflammatory skin disease, particularly for sensitive areas, maintenance treatment, and steroid-sparing care. This session reviews targeted topical agents and how they fit into pediatric treatment plans alongside corticosteroids, calcineurin inhibitors, phototherapy, and systemic therapies. Practical guidance will address safety, tolerability, application counseling, adherence, and building regimens that families can realistically follow.
These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
- Panelist
  - Brittany Weber MD, PhD
  - Heather Goff PhD
  - Katherine Economy MD
  - Elizabeth (Lisa) Swanson MD

- Presenter
  - Emma Guttman MD, PhD
Alopecia areata has entered a new treatment era, shaped by a deeper understanding of immune pathways and expanding therapeutic options. This session connects disease mechanisms with real-world treatment selection, monitoring, relapse, durability of response, and long-term management. The focus will be on approaching alopecia areata as a chronic immune-mediated disease, with attention to severity, comorbidities, safety, patient goals, and counseling.
- Presenter
  - David Fisher
Melanoma care continues to evolve quickly, with advances in immunotherapy, targeted therapy, adjuvant and neoadjuvant treatment, response assessment, and toxicity management. This session translates key oncology developments into practical knowledge for dermatologists involved in diagnosis, referral, surveillance, and long-term patient care. The discussion will also address treatment-related skin findings and how systemic therapy decisions shape follow-up in dermatology practice.
- Presenter
  - Katherine Economy MD
Pregnancy can alter the course of inflammatory and autoimmune skin disease, while treatment decisions must account for maternal disease control, fetal safety, and lactation planning. This session reviews practical management considerations for conditions such as psoriasis, atopic dermatitis, lupus-related skin disease, hidradenitis suppurativa, pemphigoid gestationis, and other complex dermatoses. The emphasis is on medication selection, flare management, risk communication, and coordination with maternal-fetal medicine.
- Panelist
  - David Fisher
  - Emma Guttman MD, PhD
  - Katherine Economy MD
- Presenter
  - Elizabeth (Lisa) Swanson MD
Targeted therapies are reshaping pediatric dermatology, offering new options for children with inflammatory, immune-mediated, and genetic skin diseases. This session reviews current and emerging systemic treatments, including biologics, JAK inhibitors, and other pathway-directed therapies. Key considerations include age-specific safety, monitoring, infection risk, vaccination, family counseling, and matching treatment intensity to disease burden.
- Presenter
  - Scott Elman MD
Autoimmune blistering diseases require early recognition, careful testing, and individualized treatment planning. This session offers a practical framework for evaluating blistering disorders, including morphology, biopsy technique, direct and indirect immunofluorescence, serologies, and key clinical differentiators. Treatment discussion will include corticosteroids, steroid-sparing agents, biologics, infection prevention, wound care, and monitoring for complications.
- Presenter
  - Tiffany Mayo
Diagnosis and treatment in skin of color require attention to morphology, pigmentary response, scarring risk, hair practices, cultural context, and patient priorities. This session reviews practical diagnostic pearls for common and complex dermatologic conditions that may present differently across skin tones. Topics include inflammatory disease, pigmentary disorders, acne, alopecia, procedural planning, and counseling around post-inflammatory hyperpigmentation or hypopigmentation.
- Presenter
  - Elizabeth (Lisa) Swanson MD
Photoprotection counseling has become more complex as patients ask about ingredients, visible light, mineral versus chemical filters, skin tone, environmental exposure, tolerability, and cosmetic elegance. This session reviews current and emerging sunscreen technologies, formulation advances, and practical recommendations across age groups and skin types. It will also address misinformation, adherence, and tailored counseling for patients with photosensitivity, pigmentary concerns, acne-prone skin, atopic dermatitis, or cosmetic preferences.
These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
- Panelist
  - Scott Elman MD
  - Tiffany Mayo
  - Elizabeth (Lisa) Swanson MD
- Presenter
  - Ryan Stidham MD, MS, AGAF
Anti-obesity medications and weight-loss procedures can produce gastrointestinal effects that influence adherence, nutrition, quality of life, and downstream dermatologic concerns. This session reviews common tolerability issues, including nausea, vomiting, constipation, reflux, diarrhea, malabsorption, nutritional deficiencies, and post-procedural complications. The discussion will help dermatology clinicians better understand the GI context behind skin, hair, and wound-related changes seen during weight-loss treatment.
- Presenter
  - Scott Elman MD
Some rashes require immediate recognition and decisive action. This session focuses on high-stakes dermatologic emergencies, including SJS/TEN, DRESS, acute generalized exanthematous pustulosis, erythroderma, and other severe cutaneous adverse reactions. The session will emphasize early warning signs, medication history, triage, biopsy and lab workup, inpatient coordination, and treatment decisions that can change outcomes.
- Presenter
  - Tiffany Mayo
Non-scarring alopecia includes a broad range of conditions beyond alopecia areata, from telogen effluvium and androgenetic alopecia to traction alopecia, nutritional contributors, endocrine disorders, and medication-related hair loss. This session reviews diagnostic patterns, history-taking, scalp examination, laboratory evaluation, and treatment approaches. Special attention will be given to identifying reversible causes and counseling patients on realistic timelines for regrowth.
- Panelist
  - Scott Elman MD
  - Tiffany Mayo
  - Elizabeth (Lisa) Swanson MD
  - Ryan Stidham MD, MS, AGAF
- Presenter
  - David Fisher
Immune checkpoint inhibitors have transformed cancer treatment across melanoma and many other tumor types, creating new opportunities and new toxicities for dermatologists to understand. This session reviews current and emerging uses of checkpoint blockade, mechanisms of response and resistance, combination strategies, and future directions in immuno-oncology. Dermatology-relevant considerations include cutaneous immune-related adverse events, coordination with oncology, and the expanding role of dermatologists in supportive cancer care.
- Presenter
  - Ryan Stidham MD, MS, AGAF
Inflammatory bowel disease is closely linked to dermatologic disease, both through shared inflammatory pathways and treatment-related effects. This session reviews common and complex skin manifestations of IBD, including erythema nodosum, pyoderma gangrenosum, aphthous disease, psoriasis, hidradenitis suppurativa overlap, and medication-associated eruptions. The discussion will highlight how GI disease activity, biologic selection, paradoxical reactions, and multidisciplinary coordination influence skin outcomes.
These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
- Panelist
  - David Fisher
  - Ryan Stidham MD, MS, AGAF

- Presenter
  - Meghan Heberton MD
Immune checkpoint inhibitors can cause a broad spectrum of cutaneous toxicities, ranging from mild eruptions to severe inflammatory, autoimmune, and blistering disorders. This session focuses on practical oncodermatology management, including grading toxicity, selecting topical or systemic treatment, determining when therapy can continue, and recognizing when urgent oncology coordination is needed. The goal is to support effective cancer treatment while minimizing dermatologic morbidity.
- Presenter
  - Heather Goff PhD
Cutaneous T-cell lymphoma can mimic common inflammatory dermatoses, leading to delayed diagnosis and uncertainty in management. This session reviews clinical clues, biopsy strategy, staging workup, and treatment selection for CTCL in everyday dermatology practice. Topics include early-stage disease, skin-directed therapies, systemic options, monitoring, referral timing, and communication with patients who may face a prolonged diagnostic journey.
- Presenter
  - Manisha Thakuria
Rare cutaneous tumors can be easy to miss but may carry significant morbidity or mortality when diagnosis is delayed. This session reviews high-risk clinical clues, diagnostic pathways, staging considerations, and treatment advances for uncommon skin cancers and adnexal tumors. Emphasis will be placed on recognizing when a lesion does not fit routine patterns, when to escalate evaluation, and how multidisciplinary care shapes outcomes.
- Panelist
  - Meghan Heberton MD
  - Heather Goff PhD
  - Manisha Thakuria
- Presenter
  - Misha Rosenbach MD
Cutaneous sarcoidosis can present with a wide range of morphologies and may provide the first clue to systemic disease. This session reviews clinical patterns, biopsy findings, systemic evaluation, and treatment options for localized and widespread disease. The discussion will connect skin findings with pulmonary, ocular, cardiac, neurologic, and other systemic considerations, helping dermatologists determine when broader workup or specialty referral is needed.
- Presenter
  - Jennifer Cao MD
Pigmented lesions involving the eye and periocular region can raise important diagnostic and referral questions for dermatologists. This session reviews key features of benign and malignant pigmented ocular lesions, including when ocular melanoma should be considered. The discussion will address clinical warning signs, referral pathways, imaging and diagnostic evaluation, treatment advances, and dermatology�s role in recognizing lesions that require ophthalmic oncology expertise.
- Presenter
  - Misha Rosenbach MD
The spectrum of neutrophilic dermatoses continues to expand as new disease entities, evolving diagnostic criteria, and emerging targeted therapies reshape clinical practice. This session provides a practical update on disorders including Sweet syndrome, pyoderma gangrenosum, neutrophilic eccrine hidradenitis, bowel-associated dermatosis-arthritis syndrome, and VEXAS syndrome, highlighting the clinical features that distinguish these often-overlapping conditions.
These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
- Panelist
  - Misha Rosenbach MD
  - Jennifer Cao MD
These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
- Presenter
  - Tiffany Mayo
Scarring alopecias require early recognition and prompt treatment to prevent irreversible hair loss. This session focuses on lichen planopilaris and related cicatricial alopecias, including diagnostic clues, trichoscopic findings, biopsy strategy, disease activity assessment, and treatment escalation. The discussion will include anti-inflammatory approaches, symptom control, patient counseling, and long-term monitoring for stabilization rather than full regrowth.
- Presenter
  - Emma Guttman MD, PhD
Chronic itch is increasingly understood as a complex neuroimmune process with distinct pathways, triggers, and treatment targets. This session reviews emerging mechanisms in pruritus, including inflammatory signaling, neural sensitization, barrier dysfunction, and systemic contributors. The discussion will connect evolving science with therapeutic development, helping clinicians better classify itch, identify underlying drivers, and consider new or emerging treatment approaches.
- Presenter
  - James Krueger MD, PhD
Dermatologic diagnosis is moving beyond morphology alone, with biomarkers, molecular profiling, and precision medicine tools beginning to shape classification and treatment decisions. This session explores emerging diagnostic approaches across inflammatory disease, skin cancer, and complex dermatoses. Topics include tissue and blood-based biomarkers, molecular signatures, treatment-response prediction, and how precision diagnostics may change clinical workflows in the coming years.
These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
- Panelist
  - Emma Guttman MD, PhD
  - James Krueger MD, PhD
  - Tiffany Mayo

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
- Presenter
  - Mark Kaufmann MD
Dermatology practices continue to face growing pressure from drug pricing, payer restrictions, prior authorization, staffing challenges, reimbursement shifts, and patient affordability concerns. This session examines operational strategies for navigating access barriers while preserving quality of care and practice sustainability. Topics include biologic and specialty medication workflows, patient support programs, team roles, financial counseling, documentation, and adapting practice systems to a more complex treatment environment.
- Presenter
  - Dan Siegel
Artificial intelligence is rapidly entering dermatology through image analysis, documentation support, triage, patient communication, clinical decision support, and practice operations. This session takes a practical look at where AI may help, where it can create risk, and how dermatology practices can evaluate tools responsibly. Discussion will include workflow integration, bias, privacy, documentation, liability, patient trust, and safeguards needed before adopting AI in routine care.
- Presenter
  - Mark Kaufmann MD
Billing and coding changes can have a direct impact on dermatology practice operations, compliance, reimbursement, and clinician workflow. This session reviews key updates relevant to dermatology and explains what they mean in day-to-day practice. The focus will be on practical application, including documentation habits, coding accuracy, common errors, audit readiness, and steps practices can take to prepare teams for changes without creating unnecessary administrative burden.
- Panelist
  - Mark Kaufmann MD
  - Dan Siegel

2027 Agenda

2027 Agenda

What to Expect

February 18-21, 2027 | Orlando

Thursday February 18, 2027

Masterclass in Dermatology

Welcome

Managing Cosmetic Sequelae of Medical Dermatology

Inflammatory Wounds and Pyoderma Gangrenosum: Diagnosis, Treatment, and Pitfalls

Ocular Inflammation in Immune-Mediated Disease

Advanced Cutaneous SCC: Therapeutic Strategy and Multidisciplinary Care

Panel Q&A

Lunch Innovation Theater (Non-Accredited)

Cardiac Imaging for Dermatologists: When Inflammation, Skin, and the Heart Intersect

Hormone Replacement Therapy in Menopause: Safety, Patient Selection, and Dermatologic Considerations

GLP-1-Associated Skin Changes: Recognition and Management

Advanced Targeted Topicals in Pediatric Dermatology: Expanding the Nonsteroidal Toolkit

Masterclass in Dermatology

Panel Q&A

Dinner Innovation Theater (Non-Accredited)

Exhibit Hall Welcome Reception

Friday February 19, 2027

Welcome

Alopecia Areata 2027: Mechanisms, Treatment, and Long-Term Management

Melanoma Through the Oncology Lens: Treatment Advances Dermatologists Should Know

Medication Safety Across Pregnancy and Fertility Treatment

Panel Q&A

Breakfast Innovation Theater (Non-Accredited)

Exhibit Hall

Targeted Therapies in Pediatric Dermatology: New and Emerging Options

Blistering Disorders: A Practical Treatment Framework

Skin of Color Dermatology: Diagnostic Pearls and Treatment Considerations in Everyday Practice

Sunscreens and Photoprotection in 2027: What's New, What Works, and What to Recommend

Masterclass in Dermatology

Panel Q&A

Lunch Innovation Theater (Non-Accredited)

GI Tolerability of Anti-Obesity Medications and Procedures

Big Bad Rashes: SJS/TEN, DRESS, and High-Stakes Dermatologic Emergencies

Non-Scarring Alopecia Beyond Autoimmunity: Diagnosis and Treatment Strategies

Panel Q&A

Immune Checkpoint Inhibitors Across Tumor Types: Present and Future

IBD and the Skin: Inflammation, Manifestations, and Treatment Effects

Masterclass in Dermatology

Panel Q&A

Dinner Innovation Theater (Non-Accredited)

Exhibit Hall

Saturday February 20, 2027

Welcome

Oncodermatology in Practice: Managing Immune Checkpoint Inhibitor Skin Toxicities

CTCL in Practice: Recognition, Staging, and Treatment Selection

Rare Cutaneous Tumors: High-Risk Clues and Treatment Advances

Panel Q&A

Breakfast Innovation Theater (Non-Accredited)

Exhibit Hall

Cutaneous Sarcoidosis: Diagnosis, Systemic Clues, and Treatment

Pigmented Ocular Lesions and Ocular Melanoma Update

Neutrophilic Dermatoses: Updates on Sweets, PG, VEXAS, and More

Masterclass in Dermatology

Panel Q&A

Lunch Innovation Theater (Non-Accredited)

Exhibit Hall

Masterclass in Dermatology

Scarring Alopecia and Lichen Planopilaris: Early Intervention and Treatment Strategy

Chronic Itch Update: Emerging Mechanisms and New Therapeutic Targets

Future Diagnostics in Dermatology: Biomarkers, Molecular Profiling, and Precision Care

Masterclass in Dermatology

Panel Q&A

Dinner Innovation Theater (Non-Accredited)

Exhibit Hall

Sunday February 21, 2027

Welcome

Masterclass in Dermatology

Breakfast Innovation Theater (Non-Accredited)

Practice Management in 2027: Drug Pricing, Access Barriers, and Operational Strategy

AI in Dermatology Practice: Use Cases, Risks, and Workflow Integration

Billing and Coding Updates for Dermatology: What Changes, What Matters, and What to Do Next

Panel Q&A

Concluding Remarks